Illumina's cancer diagnostics spinout, which is backed by a host of corporate investors, reached the $900m first close of the round in March.

University of Minnesota spinout Vigilant Diagnostics has closed a seed round that featured an unnamed Chinese investor.

Oncology drug developer Chordia Therapeutics has raised series A funding from backers including Kyoto University Innovation Capital.

Oncology drug developer Chordia Therapeutics has raised series A funding from backers including Takeda, from which it is licensing its preclinical drugs.

Texas Medical Center, a medical complex that includes multiple universities located in the US state, has launched a $25m fund to invest in early-stage healthcare technologies in Houston.

The mobility tool spinout has received an Innovate UK grant and equity funding from backers including venture firm Oxford Technology Management.

The monoclonal antibody developer, which counts EMBL Ventures and GV among its investors, had initially raised $40m when it floated last week.

Step Pharma, a developer of treatments for autoimmune diseases, has completed its series A round after closing a second tranche.

The monoclonal antibody developer, which counts GV and EMBL Ventures among its investors, had initially raised $40m when it floated last week.